Featured Articles

1. How Can A Stage-Based Program To Determine HME Applicability Benefit Your API? 9/1/2026

   Poorly soluble APIs can be converted into amorphous solid dispersions to improve bioavailability. A stage-gated approach reduces risk, optimizes polymer selection, and speeds manufacturing.

2. Preparing Global Parenteral Sites For Annex 1 Compliance 9/1/2026

   Modern sterile manufacturing requires proactive quality risk management. Robust contamination control across facilities, processes, and supply chains supports compliance and patient safety.

3. Success Factors For Pre-Filled Syringe CMO Selection 9/1/2026

   Within the past few decades, there has been a steady increase in the use of pre-filled syringes (PFS) for parenteral administration of biologics, biosimilars, and other drugs.

4. The Benefits Of Transparent Pricing 6/26/2026

   Streamline biopharma budgeting and expose hidden contract manufacturing fees. An all-inclusive pricing model ensures predictable partnerships from initial scale-up to commercial approval.

5. Addressing Regulatory Challenges For Ophthalmic Combination Products 6/17/2026

   Classifying eye drops as combination products complicates approval. Learn how identifying the primary mode of action early and aligning dual quality frameworks prevents costly launch delays.

6. What is Hot Melt Extrusion, And How Can It Benefit Your Drug Product? 6/17/2026

   Poor API solubility delays pipelines. Discover how hot-melt extrusion creates amorphous solid dispersions to break down crystal lattices and boost bioavailability via solvent-free manufacturing.

7. Monoclonal Vs Polyclonal Antibody Production- Explained Step By Step 6/17/2026

   Selecting the optimal antibody framework is critical. Discover how monoclonal and polyclonal epitope specificity impacts manufacturing complexity, batch uniformity, and long-term therapeutic efficacy.

8. What To Consider When Looking For A CDMO In Drug Substance Utilization 6/17/2026

   Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.

9. 3 Key Considerations When Choosing A Partner For Your Tech Transfer 6/15/2026

   One way to streamline tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum.

10. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.